Home
Home ยป companies

Diamyd Medical

The top 10 biotech deal terminations of 2011

The top 10 biotech deal terminations of 2011
Fierce Biotech

Diamyd ends late-stage study of diabetes-prevention drug

Diamyd ends late-stage study of diabetes-prevention drug
Fierce Biotech

J&J Returns Diabetes Drug Rights

J&J Returns Diabetes Drug Rights
Yahoo/Zacks.com

News

Blockbuster Vaccines of the Future
Fierce Biotech

News

J&J Subsidiary Joins the Diabetes Fray
Seeking Alpha
»

News

J&J cuts 2 deals for diabetes treatment
Yahoo/AP
»

News

J&J Pays $45M for Diabetes Treatment
TheStreet.com
»